Applicability of LDL-cholesterol calculation formulas in hypertriglyceridemia: Insights from the Vojvodina
Journal of Medical Biochemistry · Published 2026-01-01 · DOI 10.5937/jomb0-61948
Free full text
Authors being retrieved — see the publisher record. https://doi.org/10.5937/jomb0-61948
Abstract
Background: Low-density lipoproteins cholesterol (LDL-C) is a key parameter for assessing the risk of atherosclerotic cardiovascular disease. Direct measurement of LDL-C is not always possible due to practical or financial reasons, making the use of calculation formulas essential. The aim of this study was to evaluate the applicability of four different formulas proposed by Friedewald, Sampson, Anandaraja, and Martin-Hopkins for calculating LDL-C compared to direct method in patients with serum triglyceride levels from 4.5 to 9.0 mmol/L in the population of Vojvodina. Methods: The retrospective study included 272 subjects whose lipid status parameters were measured between June 2022 and June 2023. LDL-C was determined by the direct method (d-LDL-C) on the Alinity c analyser (Abbott Laboratories, Illinois, USA). Calculated LDL-C values were obtained using the four selected formulas. Results: The average age of participants was 52 years, and the median concentration of triglycerides was 5.48 (4.94-6.58) mmol/L. A statistically significant positive correlation was found between d-LDL-C and all calculated LDL-C (P< 0.001). Linear regression analysis of the data showed the best agreement between d-LDL-C and the Sampson formula (slope=0.97; 95% C I=0.91 - 1.04). The smallest mean difference (MD) was observed between d-LDL-C and the Sampson formula (M D=-0.032). When comparing d-LDL-C and LDL-C values obtained by calculation, only the formula of Sampson et al. did not show a statistically significant difference (P= 0.240). Conclusion: In the studied population of patients with hypertriglyceridemia, the Sampson et al. formula showed the best performance compared with the others tested.
Abstract from DOAJ. Public domain (CC0 1.0).
Read the article at the publisher →
Publication details
- Year
- 2026
Related articles
- A novel multi-analyte serum panel combining CA-125, HE4, microrna-200a, and interleukin-6 for the preclinical detection of high-grade serous ovarian carcinoma in women with pathogenic BRCA1/2 variants · Journal of Medical Biochemistry · 2026 · Same journal
- Correlation risk analysis of serum RAGE and HLI levels in patients with immune diseases · Journal of Medical Biochemistry · 2026 · Same journal
- Correlation analysis of serum CRK, CD138, and APL with the prognosis of patients with diabetic nephropathy · Journal of Medical Biochemistry · 2026 · Same journal
- A tripartite biomarker panel of systemic inflammation, immune activation, and tubular injury (IL-6, suPAR, KIM-1) predicts mortality and cardiovascular outcomes in end-stage renal disease · Journal of Medical Biochemistry · 2026 · Same journal
- Diagnostic value of combined serum protein carbonyl, 8-hydroxy-2'-deoxyguanosine, and PGC-1a detection for myocardial energy metabolism disorder in ischemic cardiomyopathy · Journal of Medical Biochemistry · 2026 · Same journal
- Novel serum biomarkers, medication adherence, and a predictive nomogram in patients with type 2 diabetes and ischemic stroke · Journal of Medical Biochemistry · 2026 · Same journal
- Cardiometabolic parameters and novel hematological indices in women with migraine · Journal of Medical Biochemistry · 2026 · Same journal
- Correlation analysis of Serum CD354 and ANGPT2 levels with the prognosis of sepsis · Journal of Medical Biochemistry · 2026 · Same journal
- Serum cytokine panel predicts cardiac outcomes following acute myocardial infarction · Journal of Medical Biochemistry · 2026 · Same journal
- Novel serum biomarkers for real-time treatment monitoring and prognostication in hepatocellular carcinoma patients · Journal of Medical Biochemistry · 2026 · Same journal